Biotech ETF Overview

With 16 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $16.39B. The average expense ratio is 0.76%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $7.46B in assets. In the last trailing year, the best performing Biotech ETF was the BBH at 2.28%. The most-recent ETF launched in the Biotech space was the Global X Genomics & Biotechnology ETF GNOM in 04/05/19.

TOP ETF PERFORMERS

LABU Direxion Daily S&P Biotech Bull 3X Shares 16.57%
UBIO ProShares UltraPro Nasdaq Biotechnology 14.45%
BIB ProShares Ultra NASDAQ Biotechnology 9.94%
CHNA Loncar China BioPharma ETF 7.53%
BBH VanEck Vectors Biotech ETF 6.51%

BOTTOM ETF PERFORMERS

LABD Direxion Daily S&P Biotech Bear 3X Shares -19.43%
ZBIO ProShares UltraPro Short Nasdaq Biotechnology -14.82%
BIS ProShares UltraShort Nasdaq Biotechnology -9.78%
GNOM Global X Genomics & Biotechnology ETF 5.01%
FBT First Trust NYSE Arca Biotechnology Index Fund 5.16%

TOP CREATIONS

XBI SPDR S&P Biotech ETF 151.05
PBE Invesco Dynamic Biotechnology & Genome ETF 0.19
CHNA Loncar China BioPharma ETF 0
GNOM Global X Genomics & Biotechnology ETF 0.00
BBP Virtus LifeSci Biotech Products ETF -0.08

TOP REDEMPTIONS

IBB iShares NASDAQ Biotechnology ETF -149.63
LABU Direxion Daily S&P Biotech Bull 3X Shares -79.71
BIB ProShares Ultra NASDAQ Biotechnology -20.03
FBT First Trust NYSE Arca Biotechnology Index Fund -13.54
BBH VanEck Vectors Biotech ETF -6.51

AUM WINNERS

XBI SPDR S&P Biotech ETF 9.37%
GNOM Global X Genomics & Biotechnology ETF 5.94%
PBE Invesco Dynamic Biotechnology & Genome ETF 5.88%
BBP Virtus LifeSci Biotech Products ETF 5.39%
CHNA Loncar China BioPharma ETF 5.34%

AUM LOSERS

ZBIO ProShares UltraPro Short Nasdaq Biotechnology -29.44%
LABD Direxion Daily S&P Biotech Bear 3X Shares -6.43%
BIS ProShares UltraShort Nasdaq Biotechnology -3.56%
BIB ProShares Ultra NASDAQ Biotechnology -2.85%
LABU Direxion Daily S&P Biotech Bull 3X Shares -0.17%

ETF Report

Sectors In Review: June 2019

Health care and real estate struggled during the month.

Features and News

How To Know What’s In Your ETF

Our free tools and resources can help with your due diligence efforts.

ETF Report

Smart Beta: Beyond The Hype

Despite all the buzz, advisors have reasons to be wary of such strategies.

Features and News

Politics Weigh On Health Care ETFs

Fears of Medicare-for-all are weighing on health care ETFs. Is this an opportunity?

Daily ETF Watch

ETF Week: Zero-Fee Funds Debut

Plus, the first space ETF rolls out.

Features and News

Worst Performing ETFs Of Q1 2019

These ETFs stand out for their poor performance in a strong year for financial markets.

ETF Report

Sectors In Review: April 2019

Sector ETFs had a mostly positive February.

ETF Report

2018 ETF.com Annual Awards

From the ETF of the Year to the People’s Choice ETF, we review the winners of each award, what drove their success and the finalists they competed against.

Features and News

CNBC ETF Edge: Biotech Getting Sick?

How you should trade biotech ETFs.